comprehensive -WSS

comprehensive

author：entertainment 2025-10-02 12:02:07 - browse：5

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： AMAs digital advisors table RPM coding reform proposal, again

entertainment

WSS

Drug companies' payments and gifts affect physicians' prescribing

Scientific mystery highlights the blind spots in genomics databases

Congress must protect the remaining independent doctors

Artificial intelligence use in health care faces greater scrutiny in 2024

Having children helps parents live longer, especially after age 80

Report cites 'urgent' need to recruit more diverse clinical trial participants

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Heart attack and stroke risk calculators need revising

Overprescribed: High cost isn't America's only drug problem

Malaria cases in Florida and Texas: Here’s what you need to know

Eli Lilly reports tirzepatide MASH success during Q4 earnings

In age of alternative facts, a scholarly course on calling out crap

Hundreds died while taking an arthritis drug, but nobody alerted patients

Bright Health sells Medicare Advantage business to Molina

AMAs digital advisors table RPM coding reform proposal, again

knowledge

Oral obesity drug from Viking Therapeutics hits key early target

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Gut bacteria may contribute to kidney autoimmunity, study finds

Drug companies' payments and gifts affect physicians' prescribing

Pancreatic cancer is often deadly, but new discoveries are raising hope

Wikipedia

focus

entertainment

hotspot